688062.SS
688062.SS
CNE100005RD2
MABWELL (SHANGHAI) BIOSCIENCE C
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 662.515.555 199.781.622
231.6%
Cost of Revenue 64.463.671 28.951.667
122.7%
Gross Profit 598.051.884 170.829.955
250.1%
1.449.285.078 1.166.107.717
24.3%
Operating Income -851.233.195 -995.277.762
14.5%
Pretax Income -956.393.708 -1.047.471.479
8.7%
Net Income Common Stockholders -969.333.663 -1.043.919.217
7.1%
-- --
--
-- --
--
ende